Spectrum Pharmaceuticals' Pivotal Trial of Captisol-Enabled (Propylene Glycol-Free) Melphalan Meets Primary Endpoint

CE Melphalan is being developed as a novel version of the well-established conditioning treatment in autologous transplant for patients ...